Capecitabine

Form: Tablets

Strength: 500 mg tablets 150 mg tablets

Reference Brands: Xeloda®(EU & US)

Category: Oncology Cancer Care

Capecitabine, marketed as Xeloda®, is an oral chemotherapy agent used in the treatment of breast cancer, colorectal cancer, and gastric cancer. As a prodrug of 5-fluorouracil (5-FU), Capecitabine is administered in 500 mg and 150 mg tablet strengths in both the US and EU markets. Its oral formulation makes it convenient for outpatient therapy and home administration. Manufactured under stringent GMP guidelines, Capecitabine is a crucial product for B2B oncology pharmaceutical companies targeting cancer care centers and oncology specialists. It presents significant opportunities for global distribution and licensing.